Atlas Trials

Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma

Clinical trial NCT00863369 · COMPLETED

Trial details

NCT number
NCT00863369
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2005-06-29
Primary completion
2016-08-25
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.